NCT06022276 2023-09-01Nimotuzumab for EGFR-amplified Advanced Pan Solid TumorsTianjin Medical University Second HospitalPhase NA Unknown46 enrolled
NCT02395068 2015-08-19Pharmacokinetics Study of Nimotuzumab in Patients With Solid TumorsBiotech Pharmaceutical Co., Ltd.Phase 1 Unknown40 enrolled